Merck & Co. Stock Gains Amid Pipeline Enthusiasm

Merck & Co., Inc.'s stock has seen a gain of about 1.6 percent versus the prior session, trading near USD 147 on the New York Stock Exchange as of September 18, 2026.

The company's pipeline and dividend yield are attracting fresh investor interest, with some analysts noting that the stock is less than USD 10 below its 52-week high of USD 156.92 while more than USD 69 above its 52-week low of USD 77.58.

An analysis from GuruFocus argued that Merck & Co. stock looks about 22.4 percent overvalued versus its GF Value estimate of USD 120.14 at a current price of roughly USD 147.05, with a trailing 12-month price-earnings ratio of about 117.55 compared with a five-year median around 20.19.

Income-oriented investors are looking to Merck & Co.'s dividend yield as a counterweight to the rich valuation multiples, which currently stand at about 2.29 percent with a payout ratio close to 1.05 and dividend growth of roughly 5.4 percent over three years.